Your search for "actinobacillus pleuropneumoniae" return 21 results.
Making the Diagnosis >
Diagnosis is required in a farm, where the disease was not yet properly described and the pathogen was not identified.
Compatibility of Coglapest® and Coglapix® vaccines in pigs >
This study was conducted in order to test the compatibility of Coglapix® and Coglapest® vaccines, when the latter was reconstituted in Coglapix®.
Comparison of vaccination with Coglapix® and targeted medication in the prevention of pleuropneumonia in pigs >
Antibiotics are frequently used for the mass repeated medication in growing and finishing phase to control pleuropneumonia. Current trend in pig farming is to reduce the overall use of antibiotics, pa...
Part 3.5 >
Processing the Scores
Efficacy of Coglapix® and Hyogen® vaccines in the Prevention of Pleuropneumonia and Enzootic Pneumonia >
The aim of this study was to compare the efficacy of Coglapix® - A.p toxoid vaccine (Ceva) and Hyogen® - M. hyo vaccine (Ceva) with competitor vaccines in the farm with the history of enzootic disease...
VETRIMOXIN® LA - Technical profile >
Vetrimoxin® LA is the leading product in the Ceva anti-infective range. Within the group of historical antibiotics, the product has an extensive experience in the market as leader in its segment being...
4. >
Summary of the Diagnostic Methods
2. >
Actinobaccilus pleuropneumoniae
1. >
Mycoplasma hyopneumoniae
Ceva Lung Program - Overview >
The Ceva Lung Program (CLP) provides an overview of the diseases associated with Actinobacillus pleuropeumoniae, Mycoplasma hyopneumoniae and Aujeszky’s disease virus.